Village Farms International, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VFF research report →
Range $3 – $9.3
Price Chart
About the company
Village Farms International, Inc. cultivates, markets, and distributes greenhouse-grown produce, including tomatoes, bell peppers, and cucumbers, across North America. The company operates through four primary divisions: Produce, Cannabis-Canada, Cannabis-U.
- CEO
- Michael A. DeGiglio
- IPO
- 2019
- Employees
- 1,128
- HQ
- Lake Mary, FL, US
Get TickerSpark's AI analysis on VFF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $245.86M
- P/E
- 10.85
- Fwd P/E
- 9.57
- PEG
- 0.11
- P/S
- 1.07
- P/B
- 0.77
- EV/EBITDA
- 4.15
- Div Yield
- 0.00%
- Gross Margin
- 43.13%
- Op Margin
- 14.71%
- Net Margin
- 9.73%
- ROE
- 7.31%
- ROIC
- 5.91%
Latest fiscal year · YoY change
- Revenue
- $215.94M-35.8%
- Gross Profit
- $87.68M+85.0%
- Op Income
- $27.39M
- Net Income
- $32.44M+190.5%
- EPS
- $0.29+190.6%
- OCF Growth
- +380.5%
- FCF Growth
- +29343.9%
- 52W High
- $4.99
- 52W Low
- $1.80
- 50D MA
- $2.71
- 200D MA
- $2.63
- Beta
- 1.45
- RSI (14)
- 27
- Avg Volume
- 893.80K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Village Farms posted record cannabis revenue and improved EBITDA in Q3, with management saying expansion projects and regulatory shifts in Europe, Canada, and Texas could drive more growth ahead.· November 9, 2026
- Record cannabis revenue of $55 million drove Q3 performance, while consolidated net sales were $66.9 million, up 5% sequentially and flat year over year.
- Adjusted EBITDA improved to $18.2 million, or 27% of sales, up 18% sequentially; net income was $10 million, or $0.08 per share.
- Gross margin was pressured by softer Canadian trim pricing, which management said was down about 75% year over year, but they expect normalization in Q4.
- International exports rose 75% year over year to $20.8 million, with management emphasizing resilient EU GMP pricing and strong demand despite supply constraints.
- The company ended with about $80 million in cash and said Delta 2, Groningen, and potential Texas and Delta 1 expansions create further upside capacity.
Q3 consolidated net sales were $66.9 million, up 5% sequentially and level with Q3 last year. Net income from continuing operations was $10 million, or $0.08 per share, versus $10.8 million, or $0.09 per share, in Q3 last year. Consolidated gross margin was 44%, down from 48% last year and 47% in Q2. Adjusted EBITDA from continuing operations was $18.2 million, or 27% of sales, compared with $20.7 million last year and $15.4 million in Q2. Cannabis net sales reached a record $55 million, with international exports up 75% year over year to $20.8 million, Canadian branded sales at $25.3 million, Canadian non-branded sales at $3.3 million, Netherlands sales at $2.8 million, and U.S. cannabis sales at $2.8 million. Management said Q4 should see normalization in Canadian trim pricing and noted Delta 2 is on track for completion in Q1 with a full 40 metric ton annual run rate by mid-next year; Groningen is fully planted and expected to support stronger revenue growth in Q4 and next year; and the company remains in a strong cash position with about $80 million in cash, $39 million of long-term debt, and an undrawn $10 million revolver.
Michael DeGiglio framed the quarter as evidence that Village Farms is building a differentiated global cannabis platform before receiving full benefit from its expansion projects. He repeatedly emphasized EU GMP-compliant supply, saying pricing on that product has not been lowered and that demand continues to outpace supply. His tone was confident and expansionary, with particular emphasis on improving conditions in Europe, continued strength in Canada, and a newly energized push toward Texas as U.S. policy changes.
Hamid Shekarchi focused on the financial bridge between the quarter’s results and the company’s growth investments. He cited gross margin of 44% versus 48% last year, SG&A at 24% of sales versus 23% last year, adjusted EBITDA of $18.2 million versus $20.7 million last year, and year-to-date adjusted EBITDA of $43.5 million, which he said is up 18% excluding last year’s $4.3 million vendor settlement. He also highlighted cash flow from operations of $9.5 million in the quarter, approximately $80 million in cash at quarter-end, $17.3 million of year-to-date CapEx mainly for Delta 2 and Groningen, long-term debt of about $39 million at a weighted-average rate of 5.7%, and a strong net cash position of $41 million. He added that Q4 seasonality could pressure revenue, particularly in produce and international order timing.
Analysts focused on three main issues: EU GMP pricing in Europe, trim pricing in Canada, and how Village Farms could enter Texas cannabis production. Management said EU GMP pricing remains resilient because compliant source-of-production supply is scarce, that it has not lowered pricing, and that tighter regulation around conversion pathways could eventually create shortages for truly compliant product. On Canadian trim, they said Q3 likely marked the trough, with demand rebounding and supply-demand rebalance improving forward pricing. On Texas, management said it is mobilizing plans for its Monahans greenhouse and believes it can bring the facility online within 12 months, while still pursuing all permissible pathways to participate if the state’s regulatory environment opens up further.
The company showed it can generate record cannabis sales, strong cash flow, and improved sequential EBITDA even before Delta 2 and Groningen are fully contributing. Management sees favorable supply-demand conditions in EU GMP cannabis, improving competitive dynamics in Canada, and a potentially meaningful Texas opening after the midterms. They also ended with significant cash, low leverage, and multiple expansion levers already underway.
Gross margin declined year over year because Canadian trim pricing fell sharply, and management acknowledged Canada has not met its mid-single-digit growth target in recent quarters. International and Dutch revenue can be lumpy, with management warning about holiday seasonality and shipment timing, while U.S. hemp/CBD businesses still face regulatory uncertainty. The Texas opportunity is still contingent on legislation and licensing, and management’s route-to-market plans there remain preliminary.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 89.5%
- Shares Outstanding
- 122.32M
- Float Shares
- 109.45M
of shares held by institutions
106 13F filers
Buy/sell ratio 2.11. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for VFF, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Kenny MarchantHouse · TX24 | Buy | Nov 20, 20 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Citadel Advisors LLC | 4.52M | ▼ 2.06M |
| Advisorshares Investments LLC | 2.59M | ▼ 842.87K |
| Tidal Investments LLC | 2.19M | ▲ 11.11K |
| American Century Companies Inc | 1.56M | ▲ 405.03K |
| Renaissance Technologies LLC | 1.50M | ▼ 102.06K |
| Two Sigma Investments, LP | 1.42M | ▼ 1.01M |
| Timelo Investment Management Inc. | 1.37M | ▲ 534.34K |
| Morgan Stanley | 1.01M | ▲ 314.76K |
| Susquehanna International Group, Llp | 780.88K | ▲ 250.36K |
| Bridgeway Capital Management, LLC | 732.40K | ▲ 185.78K |
| Two Sigma Advisers, LP | 723.23K | ▼ 81.07K |
| Qube Research & Technologies Ltd | 678.53K | ▼ 276.56K |
Held by 19 ETFs
Biggest fund positions in VFF by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Oct 13, 26 | Gillin Ann Lefever | other | 42,136 |
| Oct 13, 26 | Trupiano Yvonne | other | 34,091 |
| Sep 22, 26 | Woodward Christopher C. | buy | 10,000 |
| Sep 22, 26 | DEGIGLIO MICHAEL A | buy | 35,000 |
| Sep 9, 26 | Shekarchi Hamid | other | 0 |
| Sep 9, 26 | Shekarchi Hamid | other | 0 |
| Sep 9, 26 | Shekarchi Hamid | other | 0 |
| Sep 9, 26 | Shekarchi Hamid | other | 0 |
| Sep 9, 26 | Shekarchi Hamid | other | 0 |
| Sep 9, 26 | Shekarchi Hamid | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our VFF coverage
Recent articles, reports, and earnings notes.
No research on VFF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VFF report →Village Farms Well Positioned For Entry Into Texas Cannabis Markets (Rating Upgrade)
seekingalpha.com · Nov 11
Village Farms International, Inc. (VFF) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 9
Village Farms International Q3 Earnings Call Highlights
marketbeat.com · Nov 9
Village Farms (VFF) Tops Q3 Earnings and Revenue Estimates
zacks.com · Nov 9
Village Farms International Reports Q3 2026 Results Driven by Record Cannabis Revenues
globenewswire.com · Nov 9
Village Farms Applauds Budget 2026 Common Cannabis Excise Stamp
globenewswire.com · Nov 6
Village Farms Expands Global Cannabis Capacity as International Growth Accelerates
marketbeat.com · Oct 30
Village Farms International to Report Q3 2026 Results on November 9, 2026
globenewswire.com · Oct 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.